15-40281772-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001190479.3(ANKRD63):āc.815T>Cā(p.Leu272Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000658 in 1,535,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001190479.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD63 | NM_001190479.3 | c.815T>C | p.Leu272Pro | missense_variant | 1/1 | ENST00000434396.2 | NP_001177408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD63 | ENST00000434396.2 | c.815T>C | p.Leu272Pro | missense_variant | 1/1 | 6 | NM_001190479.3 | ENSP00000399547.1 | ||
PLCB2 | ENST00000560009.1 | n.394+2667T>C | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152230Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000546 AC: 7AN: 128222Hom.: 0 AF XY: 0.0000285 AC XY: 2AN XY: 70220
GnomAD4 exome AF: 0.0000405 AC: 56AN: 1382716Hom.: 0 Cov.: 35 AF XY: 0.0000308 AC XY: 21AN XY: 682308
GnomAD4 genome AF: 0.000295 AC: 45AN: 152344Hom.: 0 Cov.: 34 AF XY: 0.000309 AC XY: 23AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | The c.815T>C (p.L272P) alteration is located in exon 1 (coding exon 1) of the ANKRD63 gene. This alteration results from a T to C substitution at nucleotide position 815, causing the leucine (L) at amino acid position 272 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at